BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29297603)

  • 1. APC gene promoter aberrant methylation in serum as a biomarker for breast cancer diagnosis: A meta-analysis.
    Qian X; Ruan L
    Thorac Cancer; 2018 Feb; 9(2):284-290. PubMed ID: 29297603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
    Liu F; Lu X; Zhou X; Huang H
    Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the association between APC promoter methylation and breast cancer.
    He K; Zhang L; Long X
    Oncotarget; 2016 Jun; 7(25):37920-37930. PubMed ID: 27191268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer.
    Yan R; Chi L; Zheng X; Sun R; You J; Ye X
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e116-8. PubMed ID: 26728668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review.
    Liang TJ; Wang HX; Zheng YY; Cao YQ; Wu X; Zhou X; Dong SX
    Oncotarget; 2017 Jul; 8(28):46468-46479. PubMed ID: 28515349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis.
    Hu B; Zhang H; Wei H; Wang Z; Zhang F; Wang X; Li L
    Thorac Cancer; 2017 Sep; 8(5):410-416. PubMed ID: 28497891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer].
    Liu Z; Yang L; Cui DX; Liu BL; Zhang XB; Ma WF; Zhang Q
    Ai Zheng; 2007 Jun; 26(6):586-90. PubMed ID: 17562262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients.
    Debouki-Joudi S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Cancer Biomark; 2017; 18(2):133-141. PubMed ID: 27983523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of APC and RARβ2 genes in breast cancer patients.
    Swellam M; Abdelmaksoud MD; Sayed Mahmoud M; Ramadan A; Abdel-Moneem W; Hefny MM
    IUBMB Life; 2015 Jan; 67(1):61-8. PubMed ID: 25684670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of secreted frizzled-related protein 2 gene promoter hypermethylation in stool for colorectal cancer: A meta-analysis.
    Zhou Z; Zhang H; Lei Y
    J Cancer Res Ther; 2016 Oct; 12(Supplement):30-33. PubMed ID: 27721248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
    Zhou X; Lu X; Wu H; Liu J; Huang H
    Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.
    Zhou D; Tang W; Wang W; Pan X; An HX; Zhang Y
    PeerJ; 2016; 4():e2203. PubMed ID: 27478702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
    Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.